Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) — Cash Flow Reinvestment Rate
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has a Cash Flow Reinvestment Rate of 0.95x as of September 2025, reinvesting CN¥42.81 Million (capex CN¥42.81 Million ) from operating cash flow of CN¥45.11 Million. Explore 605016 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. across 10 annual periods. Also explore 605016 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
Year-by-year capital reinvestment analysis for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.. For live market cap and broader valuation context, see 605016 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.19x | CN¥432.47 Million | CN¥135.45 Million | CN¥296.80 Million | ▲ +146.0% |
| 2024 | 1.30x | CN¥390.49 Million | CN¥300.89 Million | CN¥281.81 Million | ▼ -52.8% |
| 2023 | 2.75x | CN¥535.70 Million | CN¥194.63 Million | CN¥311.98 Million | ▼ -2.4% |
| 2022 | 2.82x | CN¥422.50 Million | CN¥149.82 Million | CN¥175.60 Million | ▼ -23.3% |
| 2021 | 3.67x | CN¥353.51 Million | CN¥96.20 Million | CN¥55.82 Million | ▲ +362.0% |
| 2020 | 0.80x | CN¥96.91 Million | CN¥121.82 Million | CN¥58.66 Million | ▼ -60.9% |
| 2019 | 2.03x | CN¥130.38 Million | CN¥64.08 Million | CN¥56.49 Million | ▲ +105.8% |
| 2018 | 0.99x | CN¥88.11 Million | CN¥89.12 Million | CN¥88.11 Million | ▲ +206.0% |
| 2017 | 0.32x | CN¥36.66 Million | CN¥113.47 Million | CN¥36.66 Million | ▼ -30.8% |
| 2016 | 0.47x | CN¥28.08 Million | CN¥60.10 Million | CN¥28.08 Million | — |